We are live on ! Find out more
CA

Corrado Advisors Portfolio holdings

AUM $217M
1-Year Est. Return 26.96%
This Fund
S&P 500
This Quarter Est. Return
+8.04%
1 Year Est. Return
+26.96%
3 Year Est. Return
+64.05%
5 Year Est. Return
+51.09%
10 Year Est. Return
+157.45%
AUM
$230M
AUM Growth
+$24.2M
Cap. Flow
+$8.98M
Cap. Flow %
3.91%
Top 10 Hldgs %
55.88%
Holding
74
New
6
Increased
20
Reduced
25
Closed
4

Top Buys

Rank Stock Value
1
FEZ icon
State Street SPDR EURO STOXX 50 ETF
FEZ
+$6.06M
2
OSG
Octave Specialty Group
OSG
+$2.29M
3
PCI
PIMCO Dynamic Credit and Mortgage Income Fund
PCI
+$1.09M
4
GLPI icon
Gaming and Leisure Properties
GLPI
+$1.04M
5
GG
Goldcorp Inc
GG
+$902K

Top Sells

Rank Stock Value
1
NOV icon
NOV
NOV
+$1.58M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.1M
3
GLDI icon
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
+$993K
4
HCR
Hi-Crush Inc. Common Stock
HCR
+$823K
5
PRIS.B
PROMOTORA DE INFORMACIONES SA ADR REPSTG 4 CL B CONV SHS
PRIS.B
+$572K

Sector Composition

Rank Sector Weight
1 Industrials 16.61%
2 Real Estate 16.22%
3 Energy 16.03%
4 Materials 15.86%
5 Consumer Discretionary 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
51
Merck
MRK
$371B
$390K 0.17%
7,059
– –
HPQ icon
52
HP
HPQ
$29.4B
$362K 0.16%
23,676
– –
HAL icon
53
Halliburton
HAL
$30.9B
$355K 0.15%
5,000
-99
-2% -$6.34K
ANAC
54
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$352K 0.15%
19,840
-8,600
-30% -$138K
GS icon
55
Goldman Sachs
GS
$302B
$329K 0.14%
1,964
– –
DKL icon
56
Delek Logistics
DKL
$3.22B
$276K 0.12%
8,000
– –
XOM icon
57
ExxonMobil
XOM
$656B
$274K 0.12%
2,721
– –
JNJ icon
58
Johnson & Johnson
JNJ
$663B
$266K 0.12%
2,545
– –
F icon
59
Ford
F
$58.3B
$245K 0.11%
14,200
– –
CVX icon
60
Chevron
CVX
$409B
$236K 0.1%
1,809
-250
-12% -$31.1K
BAC icon
61
Bank of America
BAC
$438B
$225K 0.1%
14,639
-3,520
-19% -$54.7K
VLY icon
62
Valley National Bancorp
VLY
$7.75B
$208K 0.09%
21,000
– –
GENC icon
63
Gencor Industries
GENC
$270M
$204K 0.09%
27,750
– –
CLF icon
64
Cleveland-Cliffs
CLF
$7.13B
$143K 0.06%
10,000
– –
NOK icon
65
Nokia
NOK
$56.2B
$90K 0.04%
11,850
– –
ECYT
66
DELISTED
Endocyte, Inc. Common Stock
ECYT
$71K 0.03%
10,775
-4,900
-31% -$55.2K
ATRS
67
DELISTED
Antares Pharma, Inc.
ATRS
$37K 0.02%
13,750
– –
ACAD icon
68
Acadia Pharmaceuticals
ACAD
$4.83B
– –
-45,075
Closed -$1.1M
ARWR icon
69
Arrowhead Research
ARWR
$12.2B
– –
-24,350
Closed -$400K
BOND icon
70
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.6B
– –
-3,395
Closed -$362K
GLDI icon
71
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
$33M
– –
-3,558
Closed -$993K
1 2
3

Similar funds

ECM
English Capital Management Bloomfield Hills, Michigan $217M AUM 37.8% 1-Year Est. Return
DCM
Delta Capital Management Red Bank, New Jersey $217M AUM 67.79% 1-Year Est. Return
CWM
Carolina Wealth Management Greenville, North Carolina $217M AUM
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
HIMS
Hager Investment Management Services New London, New Hampshire $217M AUM 56.89% 1-Year Est. Return
PP
Pearl Planning Dexter, Michigan $217M AUM
EF
Envision Financial Brookfield, Wisconsin $217M AUM 17.78% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

Corrado Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Corrado Advisors held 74 positions worth $230M, up 12% from $205M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Corrado Advisors deployed $8.98M of net new capital in Q2 2014, opening 6 new positions and adding to 20 existing holdings. Its largest new stake was State Street SPDR EURO STOXX 50 ETF: 139,190 shares worth $6.02M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was NOV, an estimated $1.58M trimmed.

  • Corrado Advisors's largest Q2 2014 buy was State Street SPDR EURO STOXX 50 ETF: 139,190 shares worth $6.02M.
  • Corrado Advisors added most to Octave Specialty Group in Q2 2014, an estimated $2.29M increase.
  • Corrado Advisors's biggest Q2 2014 reduction was NOV, cutting an estimated $1.58M.
  • Corrado Advisors fully exited Acadia Pharmaceuticals in Q2 2014, selling an estimated $1.1M.
  • Corrado Advisors's ten largest holdings make up 56% of its $230M portfolio in Q2 2014.
  • Corrado Advisors opened 6 new positions and closed 4 in Q2 2014.
  • Corrado Advisors's portfolio value rose 12% quarter-over-quarter to $230M.

Based on Corrado Advisors's 13F filing for Q2 2014, filed 21 Jul 2014.